Six Mid-Cap stocks for upto 25% returns

Watching the stock market’s pulse? Analysts are excited by these six mid-sized companies that could rally more than 25% in the near term. These mid-cap stocks have strong fundamentals, healthy balance sheets, and favourable sector trends. Top brokerages have tagged each with a clear target price, pointing to solid upside potential. If you want to spice up your portfolio, these picks deserve a closer look.

The optimism centres on sectors ranging from consumer goods to financial services, pharmaceuticals, and infrastructure. With improving earnings, stable demand, and supportive economic cues, these firms are poised to outperform. Many have consistent revenue growth and manage costs efficiently. The combination of low valuations and positive analyst views makes the case even stronger.

Here is a quick stock-wise summary of target prices and upside potential:

– Crompton Greaves: Target ₹430; Upside 25%

– Emami: Target ₹717; Upside 25%

– Aurobindo Pharma: Target ₹1,411; Upside 23%

– ACC: Target ₹2,246; Upside 14%

– Ashok Leyland: Target ₹143; Upside 14%

– Lupin: Target ₹2,260; Upside 15%

While prospects look bright, do your homework before investing. Consider your risk appetite and investment horizon, and seek advice if needed.

These recommendations come from leading brokerages after thorough and independent research and analysis